LIFE:CA:TSX-Evolve Global Healthcare Enhanced Yield Fund Hedged Units (CAD)

ETF | Sector Equity |

Last Closing

CAD 18.31

Change

-0.06 (-0.33)%

Market Cap

CAD 0.22B

Volume

0.03M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-15 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

-0.19 (-0.51%)

CAD 3.27B
ZWU:CA BMO Covered Call Utilities ETF

+0.11 (+0.97%)

CAD 1.79B
XIT:CA iShares S&P/TSX Capped Informa..

+0.01 (+0.02%)

CAD 0.82B
TXF:CA First Asset Tech Giants Covere..

-0.07 (-0.42%)

CAD 0.61B
HTA:CA Harvest Tech Achievers Growth ..

-0.11 (-0.72%)

CAD 0.59B
XHC:CA iShares Global Healthcare (CAD..

-0.25 (-0.40%)

CAD 0.57B
ZUT:CA BMO Equal Weight Utilities Ind..

+0.23 (+1.03%)

CAD 0.51B
XUT:CA iShares S&P/TSX Capped Utiliti..

+0.21 (+0.74%)

CAD 0.37B
CWW:CA iShares Global Water Common Cl..

+0.46 (+0.81%)

CAD 0.30B
HUTL:CA Harvest Equal Weight Global Ut..

+0.02 (+0.11%)

CAD 0.29B

ETFs Containing LIFE:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.93% 54% F 42% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.93% 54% F 40% F
Trailing 12 Months  
Capital Gain -12.14% 14% F 17% F
Dividend Return 2.30% 55% F 39% F
Total Return -9.84% 17% F 17% F
Trailing 5 Years  
Capital Gain -12.06% 11% F 19% F
Dividend Return 35.21% 76% C+ 76% C+
Total Return 23.15% 17% F 31% F
Average Annual (5 Year Horizon)  
Capital Gain 0.14% 23% F 31% F
Dividend Return 1.32% 11% F 26% F
Total Return 1.18% 53% F 43% F
Risk Return Profile  
Volatility (Standard Deviation) 6.73% 97% N/A 86% B+
Risk Adjusted Return 19.65% 20% F 35% F
Market Capitalization 0.22B 62% D 47% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.